---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-045804"
form_type: "8-K"
ticker: "CTNM"
cik: "0001855175"
company_name: "Contineum Therapeutics, Inc."
filed_at: "2026-06-26T20:48:50+00:00"
generated_at: "2026-06-26T20:50:11.784503+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# Contineum Therapeutics stockholders elect three Class II directors at 2026 annual meeting

## Summary
- Three Class II directors elected: Evert Schimmelpennink, Lori M. Lyons-Williams, and Diego Miralles, M.D.
- Broker non-votes of 6,133,812 shares on each director election.
- Ratification of Ernst & Young LLP as independent auditor for FY 2026: 28,021,047 votes for, 16,104 against.
- Record date April 27, 2026; 32,723,877 shares of Class A common stock outstanding and entitled to vote.

## SEC filing metadata
- accession: 0001628280-26-045804
- form_type: 8-K
- ticker: CTNM
- cik: 0001855175
- company_name: Contineum Therapeutics, Inc.
- filed_at: 2026-06-26T20:48:50+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/0001628280-26-045804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855175/000162828026045804/ctnm-20260626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-045804
- JSON: https://secwatch.observer/filing/0001628280-26-045804.json
- Plain text: https://secwatch.observer/filing/0001628280-26-045804.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.